Cargando…

Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy

Detalles Bibliográficos
Autor principal:	Cho, Chang Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945251/ https://www.ncbi.nlm.nih.gov/pubmed/29724087 http://dx.doi.org/10.5009/gnl18113

Ejemplares similares

Prognostic Significance of Tumor Regression Grade after Preoperative Chemoradiotherapy for Rectal Cancer
por: Kim, Byung Chun
Publicado: (2011)

Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
por: Oshima, Minoru, et al.
Publicado: (2020)

The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy
por: Lee, Byung Min, et al.
Publicado: (2018)

Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer
por: Chang, Pei-Hung, et al.
Publicado: (2017)

Chemoradiotherapy for Head and Neck Cancer
por: D’Onofrio, Ida, et al.
Publicado: (2023)

What are the most important prognostic factors in patients with residual rectal cancer after preoperative chemoradiotherapy?
por: Kim, Sol-Min, et al.
Publicado: (2019)

Prognostic Nutritional Index after Chemoradiotherapy Was the Strongest Prognostic Predictor among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients
por: Ichikawa, Ken, et al.
Publicado: (2019)

Transanal Minimally Invasive Surgery After Chemoradiotherapy: Widening Scope of Indications for Local Excision
por: Kim, Min Jung, et al.
Publicado: (2017)

Additional Chemotherapy During Resting Periods After Preoperative Chemoradiotherapy in Patients With Rectal Cancer
por: Bae, Ok Suk
Publicado: (2013)

Timing of surgery following chemoradiotherapy in rectal Cancer
por: Brown, Gina, et al.
Publicado: (2014)

Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
por: Kim, Chang Hyun
Publicado: (2018)

Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy
por: Kim, Dae-Eun, et al.
Publicado: (2013)

Chemoradiotherapy in pancreatic carcinoma
por: Pathy, Sushmita, et al.
Publicado: (2009)

Gastrointestinal Hemorrhage after Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2013)

Shifting Treatment Strategies to Prevent Early Relapse of Locally Advanced Rectal Cancer After Preoperative Chemoradiotherapy
por: Park, Eun Jung
Publicado: (2020)

Clinical Prognostic Factors for Patients With Esophageal Cancer Treated With Definitive Chemoradiotherapy
por: Favareto, Sergio L, et al.
Publicado: (2021)

Hematologic Markers as Prognostic Factors in Nonmetastatic Esophageal Cancer Patients under Concurrent Chemoradiotherapy
por: Wu, Yi-Feng, et al.
Publicado: (2019)

Organ preservation for early rectal cancer using preoperative chemoradiotherapy
por: Son, Gyung Mo
Publicado: (2023)

Inflammatory and nutritional markers in patients with resectable pancreatic cancer
por: Jung, Hae Il
Publicado: (2023)

Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma
por: Kim, Byoung Hyuck, et al.
Publicado: (2015)

The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy
por: Kagami, Takuma, et al.
Publicado: (2020)

On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease
por: Hashash, Jana G, et al.
Publicado: (2021)

Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
por: Yang, Jing, et al.
Publicado: (2018)

Correlation of (18)F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy
por: Wilson, J.M., et al.
Publicado: (2017)

Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma
por: Kuwabara, Shota, et al.
Publicado: (2019)

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer
por: Kwak, Yoo-Kang, et al.
Publicado: (2014)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
por: Cho, Yeona, et al.
Publicado: (2018)

Alternating chemoradiotherapy in patients with nasopharyngeal cancer: prognostic factors and proposal for individualization of therapy
por: Goto, Yoko, et al.
Publicado: (2013)

Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences
por: Seo, Nieun, et al.
Publicado: (2019)

Nonmetastatic pancreatic cancer: Improved survival with chemoradiotherapy > 40 Gy after systemic treatment
por: Bachmayer, Sebastian, et al.
Publicado: (2018)

Differences in prognostic relevance of rectal magnetic resonance imaging findings before and after neoadjuvant chemoradiotherapy
por: Song, Kwang-Seop, et al.
Publicado: (2019)

Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer
por: Wu, Lili, et al.
Publicado: (2020)

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy
por: Zhu, Xiaofei, et al.
Publicado: (2021)

Analysis of the Prognostic Factors for Distant Metastasis after Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Head and Neck Cancer
por: Kim, Dong Hyun, et al.
Publicado: (2015)

Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapy
por: Xu, Tianlei, et al.
Publicado: (2021)

Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
por: Gaffney, David K.
Publicado: (2012)

Adjuvant hysterectomy in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
por: Shim, Seung-Hyuk
Publicado: (2019)

The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy
por: Demir, Metin, et al.
Publicado: (2022)

Impairment of Immunonutritional Status During Treatment is a Factor Associated With Oncologic Outcomes in Patients With Rectal Cancer Treated With Preoperative Chemoradiotherapy
por: Park, In Ja
Publicado: (2016)

Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer
por: Lee, Joohwan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e9cj59bl2ks1ga8q7jtqancnko